Weight-Loss Drug Alli: Tampering Investigation
WebMD News Archive
March 31, 2014 -- An investigation into tampering with bottles of the over-the-counter weight-loss drug Alli has been launched by drug maker GlaxoSmithKline and the U.S. Food and Drug Administration.
The drug company said that bottles in at least seven states -- Alabama, Florida, Louisiana, Mississippi, New York, North Carolina and Texas -- had been tampered with but did not announce a formal recall, FoxBusiness reported.
Glaxo is asking consumers to alert the company if they've bought a bottle of Alli that looks suspicious. Signs of tampering include removed labels, a detached seal, mismatched expiration dates, and pills and capsules of different colors and sizes rather than the turquoise blue Alli capsules with a dark blue ring.
The company said the outside packaging on tampered bottles may still appear authentic, FoxBusiness reported.